SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-12-001392
Filing Date
2012-01-10
Accepted
2012-01-10 17:25:54
Documents
2
Group Members
CHARLES R. KAYEJOSEPH P. LANDYWARBURG PINCUS & CO.WARBURG PINCUS PARTNERS, LLCWARBURG PINCUS PRIVATE EQUITY X, L.P.WARBURG PINCUS X LLCWARBURG PINCUS X PARTNERS, L.P.WARBURG PINCUS X, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A a12-2337_1sc13da.htm SC 13D/A 288338
2 EX-99.10 a12-2337_1ex99d10.htm EX-99.10 99745
  Complete submission text file 0001104659-12-001392.txt   390059
Mailing Address 2207 BRIDGEPOINTE PARKWAY SUITE 250 SAN MATEO CA 94404
Business Address 2207 BRIDGEPOINTE PARKWAY SUITE 250 SAN MATEO CA 94404 650-588-6404
Talon Therapeutics, Inc. (Subject) CIK: 0001140028 (see all company filings)

IRS No.: 320064979 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-79910 | Film No.: 12520678
SIC: 2834 Pharmaceutical Preparations

Mailing Address 450 LEXINGTON AVENUE NEW YORK NY 10017
Business Address 450 LEXINGTON AVENUE NEW YORK NY 10017 212-878-0600
WARBURG PINCUS LLC (Filed by) CIK: 0001162870 (see all company filings)

IRS No.: 133536050 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13D/A